Why is Bafna Pharma. falling/rising?

As of 28-Aug, Bafna Pharmaceuticals Ltd's stock price is currently at 99.24, reflecting a rise of 0.24 (0.24%). The stock has shown a positive trend recently, gaining 4.57% over the last two days and outperforming its sector by 1.08%. Over the past month, the stock has increased by 11.44%, while its year-to-date return stands at an impressive 29.73%. The company has demonstrated strong financial health, evidenced by a low Debt to EBITDA ratio of 1.30 times and significant profit growth, with a 944% increase in profits over the past year. Additionally, institutional investors have increased their stake, indicating confidence in the company's fundamentals.
In the broader market context, while the BSE500 index has experienced negative returns of -5.01% over the past year, Bafna Pharmaceuticals has managed to generate a return of 21.02%, showcasing its resilience against market trends. However, the stock's performance over the last week has been slightly negative at -0.25%, contrasting with the benchmark's decline of -2.34%. Despite a recent drop in investor participation, as indicated by a 57.22% decrease in delivery volume, the stock's liquidity remains adequate for trading. Overall, the combination of strong financial results, increasing institutional interest, and a favorable valuation compared to peers supports the stock's upward movement.